ABO-Incompatible Kidney Transplants Between Robot-Assisted vs. Open Surgery
- Conditions
- Kidney Transplantation
- Interventions
- Procedure: robot-assisted kidney transplantation
- Registration Number
- NCT06287008
- Lead Sponsor
- Asan Medical Center
- Brief Summary
While robot-assisted kidney transplantation (RAKT) offers potential benefits such as minimal postoperative pain, better cosmesis, fewer wound infections, and shorter hospital stay, its efficacy in ABO-incompatible (ABO-i) KT compared to open KT (OKT) remains understudied. This study aims to compare ABO-i KT outcomes between RAKT and OKT.
The study utilized data from 29 ABO-i RAKT and 210 ABO-i OKT cases performed at Asan Medical Center from October 2020 to February 2023. Univariate and multivariate analyses were performed to evaluate factors associated with a composite of biopsy-proven acute rejection (BPAR), de novo donor-specific antibodies (DSA), and overall graft failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 239
- Patient eligible for living donor ABO incompatible kidney transplantation
- Presenting an IsoAgglutinin immunoglobulin G titer (anti-A-B) between 1/8 and 1/128 before operation
- Patient older than 18 years and young than 80 years
- Patient able to sign an informed consent form
- Patient with comorbidities or hypersensitivity that prevent desensitization protocols
- Women who are pregnant, or who may become pregnant or breastfeeding women
- Subjects under legal protection
- Subjects participating in another interventional research protocol or in an exclusion period from another interventional research protocolPatient affiliated with a social security scheme
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description RAKT robot-assisted kidney transplantation patients who underwent "robot-assisted kidney transplantation"
- Primary Outcome Measures
Name Time Method renal function 1 year post-operative renal function measured in terms of eGFR (Estimated Glomerular Filtration Rate)
Graft survival 1 year post-operative allograft (kidney) survival
- Secondary Outcome Measures
Name Time Method . A composite of biopsy-proven acute rejection, graft failure, and the development of de novo donor-specific antibodies 1 year post-operative . A composite of biopsy-proven acute rejection, graft failure, and the development of de novo donor-specific antibodies
Trial Locations
- Locations (1)
Asan Medical Center
🇰🇷Seoul, Korea, Republic of